Our team is dedicated to a healthier world through partnerships that bring better medicines to patients faster.


Justin Mika

Justin Mika >

CEO, President

Jonah Rainey, Ph.D.

Jonah Rainey, Ph.D. >

VP of Antibody Engineering and Protein Science

Board of Directors

Larry Green, Ph.D.

Larry Green, Ph.D. >

Executive Chairman

Adam Grossman

Adam Grossman >

Board Member


James Graziano, Ph.D.

James Graziano, Ph.D. >

Senior Director, Operations

Dana Duey

Dana Duey >

Associate Director, Antibody Discovery

Jacek Ostrowski, Ph.D.

Jacek Ostrowski, Ph.D. >

Associate Director, Protein Chemistry

Ritsuko Sawada, Ph.D.

Ritsuko Sawada, Ph.D. >

Senior Scientist

Crystal Bantados

Crystal Bantados >

Senior Project Manager

Stacey Borders

Stacey Borders >

Market Development Partner

Travis Grant

Travis Grant >

Research Associate I

Ali Ataei

Ali Ataei >

Senior Research Associate I

Ranveer Jayani

Ranveer Jayani >

Scientist I

Linda Masat, Ph.D.

Linda Masat, Ph.D. >

Head of European and Strategic Business Development

Blisseth Sy

Blisseth Sy >

Director, Business Development

Our Relationship with Ablexis

We use the AlivaMab Mouse, developed by Ablexis, LLC, as the platform for your discovery project. Chosen by many leading pharmaceutical companies, this best-in-class transgenic platform generates human therapeutic antibody candidates with high potency, specificity, developability qualities and reduced chances of immunogenicity.

We founded AlivaMab Discovery Services after hearing the needs of many prospective partners wanting to outsource discovery to a scientifically-driven organization led by a team with in-the-trenches experience and real understanding of therapeutic antibody discovery and development.

To learn more visit

AllivaMab Mouse